A Study of HGS1036 in Combination With Chemotherapy in Subjects With Advanced Solid Malignancies
Clinical trial NCT01604863 · SUSPENDED
Trial details
- NCT number
- NCT01604863
- Sponsor
- Human Genome Sciences Inc., a GSK Company
- Status
- SUSPENDED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-01
- Primary completion
- 2014-06-01
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.